Intragraft drug infusion as an adjunct to balloon catheter thrombectomy for salvage of thrombosed infragenicular vein grafts: a preliminary report

Journal of Vascular Surgery
D B WalshJ L Cronenwett

Abstract

Early infragenicular vein graft thrombosis is associated with poor secondary patency, particularly when no correctable defect is identified. We have attempted to improve patency of thrombosed vein grafts by direct infusion of vasodilator and anticoagulant drugs after surgical thrombectomy. Among 212 infragenicular vein grafts, 16 (7.5%) required thrombectomy within 30 days of surgery (14 in situ saphenous vein, 1 composite vein, and 1 cephalic vein graft). Causes for failure were corrected in four (graft twist, intimal tear, suture failure, and external compression), resulting in prolonged patency. No cause for failure was apparent in the 12 remaining grafts after balloon catheter thrombectomy and arteriography. Two of these grafts occluded within 10 days despite multiple attempts at vein patch angioplasty, distal graft extension, and repeat thrombectomy with systemic anticoagulation. In the remaining 10 grafts, a small polyethylene catheter was placed in a proximal vein branch for direct intragraft drug infusion. Heparin (10 units/min) and nitroglycerin (50 micrograms/min) were the agents infused most frequently, for a mean duration of 52 hours after thrombectomy. Of these 10 infused grafts, 8 remained patent during a mean 17-...Continue Reading

References

Jul 1, 1975·Archives of Surgery·J E LiddicoatM E DeBakey
Mar 1, 1989·Radiology·K W SnidermanR E Goldberg
May 1, 1989·Archives of Surgery·A MillerM Bolduc
Aug 1, 1985·The Journal of Clinical Investigation·J Loscalzo
Sep 1, 1988·The American Journal of Cardiology·J StamlerJ Loscalzo
Sep 1, 1986·AJR. American Journal of Roentgenology·G A GardinerD P Harrington
May 1, 1983·American Journal of Surgery·J J PeckM R Gaspar
Jan 1, 1984·Journal of Vascular Surgery·A van BredaC A Athanasoulis
Mar 1, 1981·The Journal of Clinical Investigation·R I LevinK Tack-Goldman
Jul 1, 1982·Archives of Surgery·R H SamsonF J Veith
Jan 1, 1981·Annals of Surgery·A D WhittemoreJ A Mannick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.